Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Första priset efter rekorddonationen

I maj 2016 donerade Bengt Sjöberg 2 miljarder kronor - en av de största donationerna i svensk historia. Nu delas det första priset i donationens namn ut. Sjöber...

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

EMA tillsätter expertgrupp mot Zika

Erbjuder rådgivning kring vetenskapliga och regulatoriska frågor till bolag som utvecklar läkemedel och vaccin mot viruset.

Sanionas kokainstudie inledd

Bioteknikföretagets samarbetspartner TRC har påbörjat rekrytering till studien om kokainberoende.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Sprint får ny vetenskaplig rådgivare

Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.

535 miljoner till regenerativ medicin

Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Raysearch igång i Kina

Första patienten ombord i strålstudie.

Stöd till kvinnliga forskare

17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Satsar på tidig forskning

Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.

Sales Representative, Applied Biosystems

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.